about
Bendamustine and rituximab in relapsed and refractory hairy cell leukemia.How I treat hairy cell leukemia.Phase 2 study of cladribine followed by rituximab in patients with hairy cell leukemia.Cladribine with immediate rituximab for the treatment of patients with variant hairy cell leukemia.Antibody fusion proteins: anti-CD22 recombinant immunotoxin moxetumomab pasudotoxCharacterization of CD22 expression in acute lymphoblastic leukemiaTumor markers in hairy cell leukemia.How I manage patients with hairy cell leukaemia.
P2860
Q33410756-8367709C-294D-4A87-AFB9-189F20F42B52Q33579506-9EE67034-BB84-4B75-AED4-FF194A2F9ACCQ33844299-197A5C57-5827-43EF-A2AC-25818E9F04E9Q34387911-02B4B79C-6A75-4B97-9701-7849C93EBDACQ35446035-CA5A9680-B36A-4210-A70B-CA2F3A9F02E4Q35514128-36DE59D0-689E-4D91-90D2-B3A689C8D4FDQ37861182-F5437AA9-C39D-4707-882D-3E546206EA5FQ39113513-9B34DBB2-BEA6-4830-A223-DB8C3EA8639F
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Soluble CD22 as a tumor marker for hairy cell leukemia.
@en
type
label
Soluble CD22 as a tumor marker for hairy cell leukemia.
@en
prefLabel
Soluble CD22 as a tumor marker for hairy cell leukemia.
@en
P2093
P2860
P1433
P1476
Soluble CD22 as a tumor marker for hairy cell leukemia.
@en
P2093
Inger Margulies
Kakushi Matsushita
Maryalice Stetler-Stevenson
Masanori Onda
Robert J Kreitman
Satoshi Nagata
P2860
P304
P356
10.1182/BLOOD-2008-01-131987
P407
P577
2008-07-02T00:00:00Z